Marco Cavaleri | Head of Public Health Threats
European Medicines Agency

Pre-Congress Workshops - Monday 13th October @ 14:00

Vaccine Safety Workshop [PM1]

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

×

Ofer Levy / Vaccine Safety Workshop [PM1]

Ofer Levy, Director, Precision Vaccines Program,
Boston Children's Hospital

Dr. Ofer Levy is principal investigator, staff physician and the Director of the Precision Vaccines Program at Boston Children’s Hospital, Professor of Pediatrics at Harvard Medical School, and Associate Member of the Broad Institute of MIT and Harvard. The Precision Vaccines Program (PVP) is an...

CloseMore

Marco Cavaleri, Head of Public Health Threats, European Medicines Agency

×

Marco Cavaleri / Vaccine Safety Workshop [PM1]

Marco Cavaleri, Head of Public Health Threats,
European Medicines Agency

Marco Cavaleri is the Head of Public Health Threats at the European Medicines Agency (EMA). He leads EMA activities on emerging pathogens, vaccines, and antimicrobial resistance, and previously chaired the EMA’s COVID-19 Taskforce. With extensive experience in both industry and regulatory roles, he ...

CloseMore

Y. Tony Yang, Professor, The George Washington University

×

Y. Tony Yang / Vaccine Safety Workshop [PM1]

Y. Tony Yang, Professor,
The George Washington University

Y. Tony Yang, ScD, LLM, MPH, is an endowed professor (with tenure) in health policy and Associate Dean for Health Policy and Population Science at George Washington University School of Nursing. He also holds a joint appointment at the Milken Institute School of Public Health in the Department of...

CloseMore

Christine Stabell Benn, Professor, University of Southern Denmark

Peter Aaby, Professor & Founder, Bandim Health Project

Session led by: curevo-vaccine

Day 1 - Tuesday 14th October @ 09:00

Beyond Borders: Europe’s Strategic Role in Powering Vaccine Innovation and Transforming the Global Vaccine Landscape

• How can Europe’s unique ecosystem of innovation hubs, regulatory frameworks, and public-private partnerships accelerate the next generation of breakthrough vaccines?
• What strategies and incentives are needed to transform Europe’s emerging biotechs and SMEs into tomorrow’s vaccine innovation leaders?
• How can regulatory frameworks evolve to support rapid innovation while maintaining the gold standard in vaccine safety and efficacy?
• In an increasingly complex global health landscape, how can Europe balance domestic innovation priorities with its responsibility to ensure equitable worldwide vaccine access?

Jayasree Iyer, Chief Executive Officer, Access to Medicine Foundation

×

Jayasree Iyer / Beyond Borders: Europe’s Strategic Role in Powering Vaccine Innovation and Transforming the Global Vaccine Landscape

Jayasree Iyer, Chief Executive Officer,
Access to Medicine Foundation

As CEO, Jayasree K. Iyer sets the Foundation's strategy for assessing the efforts of healthcare companies to ensure their products reach more people around the world. In her discussions with global industry leaders, she engages them on the practical, effective steps they can take to...

CloseMore

Marco Cavaleri, Head of Public Health Threats, European Medicines Agency

×

Marco Cavaleri / Beyond Borders: Europe’s Strategic Role in Powering Vaccine Innovation and Transforming the Global Vaccine Landscape

Marco Cavaleri, Head of Public Health Threats,
European Medicines Agency

Marco Cavaleri is the Head of Public Health Threats at the European Medicines Agency (EMA). He leads EMA activities on emerging pathogens, vaccines, and antimicrobial resistance, and previously chaired the EMA’s COVID-19 Taskforce. With extensive experience in both industry and regulatory roles, he ...

CloseMore

Wolfgang Philipp, Principal Adviser, Chief Science Officer, European Commission Health Emergency Preparedness & Response (HERA)